HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap USD

Register to Unlock Ratings
Performance History31/03/2024
Growth of 1,000 (GBP) Advanced Graph
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap USD
Fund18.2-3.3-0.96.53.4
+/-Cat-7.85.86.97.81.1
+/-B’mrk-14.7-3.6-3.4-0.8-5.1
 
Key Stats
NAV
24/04/2024
 USD 435.35
Day Change -0.62%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU1540962054
Fund Size (Mil)
24/04/2024
 USD 23.13
Share Class Size (Mil)
24/04/2024
 USD 19.27
Max Initial Charge 3.00%
Ongoing Charge
19/02/2024
  1.77%
Investment Objective: HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap USD
The investment objective of the Sub-Fund is to achieve long-term capital growth. The goal is to generate a value trend that exceeds the performance of the NASDAQ Biotechnology Index (the “Benchmark”). No guarantee can be given that the investment objective will be achieved.
Returns
Trailing Returns (GBP)24/04/2024
YTD-2.67
3 Years Annualised-0.01
5 Years Annualised5.94
10 Years Annualised*10.07
12 Month Yield 0.00
Management
Manager Name
Start Date
Ivo Staijen
31/12/2011
Inception Date
06/09/2017
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMorningstar Gbl Biotechnology NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap USD31/12/2023
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock100.000.00100.00
Bond0.000.000.00
Property0.000.000.00
Cash0.000.000.00
Other0.000.000.00
Top 5 Regions%
United States77.54
Europe - ex Euro11.57
United Kingdom3.93
Asia - Emerging2.86
Canada2.74
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Cytokinetics IncHealthcareHealthcare6.62
Amgen IncHealthcareHealthcare5.71
Vertex Pharmaceuticals IncHealthcareHealthcare5.65
Regeneron Pharmaceuticals IncHealthcareHealthcare5.22
Neurocrine Biosciences IncHealthcareHealthcare3.92
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund P Cap USD

Related

* This share class has performance data calculated prior to the inception date, 2017-09-06. This is based upon a simulated/extended track record, using the track record of HBM Global Biotechnology Fund USD (ISIN: LI0130449403), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures